We have located links that may give you full text access.
Laser in situ Keratomileusis Corneal Flap Creation With the Nidek MK-2000 and the Carriazo Barraquer Microkeratomes.
Journal of Refractive Surgery 2000 March 3
PURPOSE: To evaluate the performance of the Nidek MK-2000 and the LSK Carriazo Barraquer microkeratomes in the creation of corneal flaps for laser in situ keratomileusis (LASLK).
METHODS: A prospective randomized study of 55 eyes of 30 patients who underwent LASLK was performed. Twelve corneal flaps were created hy the Nidek MK-2000 microkeratome (160-/«n head), 30 corneal flaps by the Carriazo Barraquer 160-¿m head microkeratome, and 13 corneal flaps by the Carriazo Barraquer 180-/tm head microkeratome. Flap thickness (evaluated by ultrasonic pachymetry), flap diameter, hinge size, and hinge-to-centerof-pupil distance were measured.
RESULTS: For the Nidek MK-2000 microkeratome, mean flap thickness was 149.58 ± 25.61 µ?? (range, 94 to 186 /im), flap diameter was 8.81 ± 0.34 mm (range, 8.4 to 9.1 mm), hinge size was 4.31 ± 0.45 mm (range, 3.9 to 4.8 mm), and hinge-to-centerof-pupil distance was 3.79 ± 0.70 mm (range, 3.9 to 4.7 mm). For the Carriazo Barraquer 160-/im head microkeratome, mean flap thickness was 123.9 ± 22.28 jttm (range, 104 to 155 /an), flap diameter was 9.08 ± 0.44 mm (range, 8.7 to 11 mm), hinge size was 4.04 ± 0.61 mm (range, 4 to 6 mm), and hinge-tocenter-of-pupil distance was 4.37 ± 0.24 mm (range, 4 to 4.5 mm). For the Carriazo Barraquer I80-/«n head microkeratome, mean flap thickness was 167.23 ± 24.92 ^m (range, 145 to 198 /nn), flap diameter was 9.12 ± 0.18 mm (range, 9 to 9.4 mm), hinge size was 4.21 ± 0.39 mm (range, 4 to 5 mm), and hinge-to-center-of-pupil distance was 4.47 ± 0.24 mm (range, 4.2 to 4.7 mm). There was no correlation between corneal curvature and flap diameter. No case was aborted due to improper corneal flap creation. An epithelial defect was found in 5 eyes after reverse movement of the Nidek MK2000 microkeratome.
CONCLUSION: The Nidek MK-2000 and the Carriazo Barraquer microkeratomes were effective, safe, and reliable in the creation of corneal flaps for LASLK. [J Refract Surg 2000;16(suppl): S272-S275].
METHODS: A prospective randomized study of 55 eyes of 30 patients who underwent LASLK was performed. Twelve corneal flaps were created hy the Nidek MK-2000 microkeratome (160-/«n head), 30 corneal flaps by the Carriazo Barraquer 160-¿m head microkeratome, and 13 corneal flaps by the Carriazo Barraquer 180-/tm head microkeratome. Flap thickness (evaluated by ultrasonic pachymetry), flap diameter, hinge size, and hinge-to-centerof-pupil distance were measured.
RESULTS: For the Nidek MK-2000 microkeratome, mean flap thickness was 149.58 ± 25.61 µ?? (range, 94 to 186 /im), flap diameter was 8.81 ± 0.34 mm (range, 8.4 to 9.1 mm), hinge size was 4.31 ± 0.45 mm (range, 3.9 to 4.8 mm), and hinge-to-centerof-pupil distance was 3.79 ± 0.70 mm (range, 3.9 to 4.7 mm). For the Carriazo Barraquer 160-/im head microkeratome, mean flap thickness was 123.9 ± 22.28 jttm (range, 104 to 155 /an), flap diameter was 9.08 ± 0.44 mm (range, 8.7 to 11 mm), hinge size was 4.04 ± 0.61 mm (range, 4 to 6 mm), and hinge-tocenter-of-pupil distance was 4.37 ± 0.24 mm (range, 4 to 4.5 mm). For the Carriazo Barraquer I80-/«n head microkeratome, mean flap thickness was 167.23 ± 24.92 ^m (range, 145 to 198 /nn), flap diameter was 9.12 ± 0.18 mm (range, 9 to 9.4 mm), hinge size was 4.21 ± 0.39 mm (range, 4 to 5 mm), and hinge-to-center-of-pupil distance was 4.47 ± 0.24 mm (range, 4.2 to 4.7 mm). There was no correlation between corneal curvature and flap diameter. No case was aborted due to improper corneal flap creation. An epithelial defect was found in 5 eyes after reverse movement of the Nidek MK2000 microkeratome.
CONCLUSION: The Nidek MK-2000 and the Carriazo Barraquer microkeratomes were effective, safe, and reliable in the creation of corneal flaps for LASLK. [J Refract Surg 2000;16(suppl): S272-S275].
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app